Skip to main content
VIVOZON PHARMACEUTICAL CO., LTD. logo

VIVOZON PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 082800 ISIN · KR7082800004 KO Manufacturing
Open in API
Filings indexed 590 across all filing types
Latest filing 2018-10-22 Declaration of Voting R…
Country KR South Korea
Listing KO 082800

About VIVOZON PHARMACEUTICAL CO., LTD.

https://www.vivozon.com/

VIVOZON PHARMACEUTICAL CO., LTD. is a research and development company specializing in the discovery and commercialization of innovative drugs, with a primary focus on pain and central nervous system (CNS) diseases. The company utilizes a multi-target drug development platform to create new chemical entities that act on multiple targets to achieve synergistic efficacy. This approach integrates efficacy-based screening from the early stages of discovery to identify candidate substances with a high potential for successful clinical development. Its lead pipeline candidate is Opiranserin (VVZ-149), a first-in-class, non-narcotic injectable analgesic for post-operative pain management. The company is actively expanding its pipeline to address a broader range of unmet medical needs within the CNS field.

Recent filings

Filing Released Lang Actions
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '임시주주총회결과' (Extraordinary General Meeting Results) and explicitly lists the outcome of a shareholder vote regarding a company split. This falls under the category of official results from shareholder votes at a general meeting.
2018-10-22 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of shares by a specific entity (JH Investment Association) in a listed company (Lumi Micro). This type of filing is used to notify the market of significant changes in share ownership (crossing thresholds), which falls under the 'Major Shareholding Notification' category.
2018-10-17 Korean
조회공시요구(풍문또는보도)에대한답변(미확정)
M&A Activity Classification · 95% confidence The document is a formal response to a regulatory inquiry (조회공시요구) regarding rumors of a merger with 'Dinona Co., Ltd.' (다이노나(주)). It confirms that the company is reviewing a potential merger and has appointed an advisor, but no final decision has been made. Since this is a regulatory disclosure regarding corporate activity (merger rumors) and does not fit into specific categories like M&A finalization or financial reports, it is classified as a general regulatory filing.
2018-10-12 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Securities Issuance Result' (증권 발행결과) announcement from Lumi Micro, detailing the completion of a third-party capital increase (유상증자). It specifies the number of shares issued, the total amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2018-10-11 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Extraordinary General Meeting of Shareholders' (주주총회소집공고) for Lumimicro Co., Ltd. It includes the meeting agenda, date, location, and detailed management reference materials (경영참고사항) such as board activity reports, director remuneration, and business overviews. This type of document is a formal solicitation of shareholder votes and information for an upcoming meeting, which falls under the Proxy Solicitation & Information Statement category.
2018-10-05 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.